Mark Packer, MD
Clinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC
Mark Packer, MD, FACS, is a Clinical Associate Professor of Ophthalmology at Oregon Health & Sciences University. He is also in private practice with Drs. Fine and Hoffman in Eugene, Oregon. His research focuses on refractive surgery and intraocular lens technology. Dr. Packer is also the principal investigator for several lasers and intraocular lenses including Carl Zeiss Meditec MEL-80 Excimer Laser, Pharmacia's aspheric Z9000 IOL, AMO's Tecnis Multifocal IOL, Visiogen's Synchrony Dual Optic Accommodative Lens, Eyeonics' accommodative Crystalens and VisionCare’s Implantable Miniaturized Telescope. Dr. Packer has publications in the Journal of Cataract and Refractive Surgery and Journal of Refractive Surgery. He has edited Refractive Lens Surgery and served as Editor for the "Functional Vision" issue of International Ophthalmology Clinics. Dr. Packer chairs the Cataract Subcommittee of the American Academy of Ophthalmology Annual Meeting Program Committee and was elected to membership in the International Intra-Ocular Implant Club. (This is me - Update Profile)
| 2001 - present | Clinical Associate Professor of Ophthalmology OREGON HEALTH & SCIENCE UNIVERSITY - CC |
|---|---|
| 2000 - present | Owner Dr's Fine Hoffman & Packer LLC |
GLG Study Groups with Mark Packer, MD(?)
| Study Group Name | Members |
|---|---|
| LASIK Surgeons (US) | 135 |
| Ophthalmologists (US) | 1033 |
| Physicians who Implant Intraocular Lenses | 197 |
| Physicians who Treat Dry Eye (US) | 126 |
GLG NewsSM
Analyses by Mark Packer, MD(?)
The media reporting on the FDA hearings on LASIK has generally highlighted unhappy patients' stories and the comments of FDA officials and panel members. However, The Washington Post's Lauran Neergard has written an insightful article that foresees an important future trend in refractive surgery....
Presbyopia correcting IOLs currently represent 5% of all IOLs implanted in the United States (about 3.5 million per year). The products available in this category include the ReSTOR multifocal IOL (Alcon), the ReZoom multifocal IOL (AMO) and the cyrstalens accommodative IOL (eyeonics). Although...
Rather than getting gobbled up by one of the big three players in Ophthalmology (B & L, Alcon and AMO), eyeonics is looking to go it alone into the public arena. The crystalens remains the only approved accommodative intraocular lens, but faces strong competition from the multifocals. ...
Alcon has suffered with its LADARVision system recalls and lawsuits, and has looked particularly troubled following AMO's acquisition of VISX. Although AMO/VISX remains the market leader for refractive correction, the Allegretto represents new technology with potential advantages in terms of accuracy...
GLG InstituteSM Seminars with Mark Packer, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Mark Packer, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms